Opticann Information

Opticann was founded by former MedReleaf executives including Neil Closner (founder and former CEO), Umar Syed (former SVP Corporate Development), Angelo Fefekos (former SVP of Clinical Affairs & Quality Compliance) and Ori Sher (former Sr. Director of Procurement and Security). Opticann Inc. is a Colorado-based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb® drug delivery system for optimized absorption and stability(bioavailability). Opticann has a supply and distribution agreement with Geocann LLC ("Geocann"), a global cannabis organization with the exclusive worldwide rights to the patented VESIsorb® delivery technology for cannabinoids, terpenes, and flavonoid formulations. The agreement between Opticann and Geocann provides Opticann exclusive distribution rights to brand and market a select portfolio of VESIsorb® formulated oral and topical CBD and CBG products to major U.S. retailers that dominate the U.S. food, drug, and mass retailer market, including CVS, Walgreens, Rite-Aid, and Walmart, among others. VESIsorb® is a leading delivery system innovation for dramatically improving the stability and absorption (bioavailability) of natural ingredients like cannabinoids, and is backed by a robust body of supporting scientific evidence spanning several decades. Opticann was acquired in October 2020 by Heritage Cannabis, a Toronto-based holdings corporation, offering innovative products to both the medical and recreational cannabis markets. Heritage Cannabis Holdings Corp. is a vertically integrated cannabis company that owns two Health Canada approved licenced producers, CannaCure Corp. and Voyage Cannabis Corp., both of which also have industrial hemp licenses.